{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:56Z","timestamp":1786979816098,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Health Science and Technology Plan Project","award":["2020QNB058"],"award-info":[{"award-number":["2020QNB058"]}]},{"name":"Scientific and Technological Plan Projects of Xiamen","award":["3502Z20194026"],"award-info":[{"award-number":["3502Z20194026"]}]},{"name":"The Key Clinical Specialty Discipline Construction Program of Fujian, P.R. China","award":["\/"],"award-info":[{"award-number":["\/"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01271-8","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T14:02:25Z","timestamp":1724853745000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Morinda Officinalis Polysaccharides Inhibit Osteoclast Differentiation by Regulating miR-214-3p\/NEDD4L in Postmenopausal Osteoporosis Mice"],"prefix":"10.1007","volume":"115","author":[{"given":"Hui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell R, O\u2019Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT et al (2016) Postmenopausal osteoporosis. Nat Rev Dis Primers 2:16069","journal-title":"Nat Rev Dis Primers"},{"issue":"5\u20136","key":"1271_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/2042018816658164","volume":"7","author":"B Eftekhar-Sadat","year":"2016","unstructured":"Eftekhar-Sadat B, Ghavami M, Toopchizadeh V, Ghahvechi AM (2016) Wrist bone mineral density utility in diagnosing hip osteoporosis in postmenopausal women. Ther Adv Endocrinol Metab 7(5\u20136):207\u2013211","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"1271_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148(3):197\u2013213","journal-title":"Ann Intern Med"},{"issue":"11","key":"1271_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/aje\/kwg081","volume":"157","author":"J Magaziner","year":"2003","unstructured":"Magaziner J, Fredman L, Hawkes W, Hebel JR, Zimmerman S, Orwig DL et al (2003) Changes in functional status attributable to hip fracture: a comparison of hip fracture patients to community-dwelling aged. Am J Epidemiol 157(11):1023\u20131031","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1271_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00198-004-1622-5","volume":"15","author":"I Hallberg","year":"2004","unstructured":"Hallberg I, Rosenqvist AM, Kartous L, Lofman O, Wahlstrom O, Toss G (2004) Health-related quality of life after osteoporotic fractures. Osteoporos Int 15(10):834\u2013841","journal-title":"Osteoporos Int"},{"issue":"10","key":"1271_CR6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","volume":"20","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633\u20131650","journal-title":"Osteoporos Int"},{"issue":"1(Special)","key":"1271_CR7","first-page":"495","volume":"33","author":"Y Deng","year":"2020","unstructured":"Deng Y, Li L, Li C, Wang F, Qu Y (2020) Efficacy of combined medication of risedronate sodium and selective estrogen receptor modulator on the postmenopausal osteoporosis. Pak J Pharm Sci 33(1(Special)):495\u2013498","journal-title":"Pak J Pharm Sci"},{"issue":"5","key":"1271_CR8","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595\u20131622","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1271_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","volume":"84","author":"KA Kennel","year":"2009","unstructured":"Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84(7):632\u2013637 (quiz 8)","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1271_CR10","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95(9):4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jep.2017.10.028","volume":"213","author":"JH Zhang","year":"2018","unstructured":"Zhang JH, Xin HL, Xu YM, Shen Y, He YQ, Hsien Y et al (2018) Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 213:230\u2013255","journal-title":"J Ethnopharmacol"},{"key":"1271_CR12","doi-asserted-by":"publisher","first-page":"104074","DOI":"10.1016\/j.compbiomed.2020.104074","volume":"127","author":"ZW Liu","year":"2020","unstructured":"Liu ZW, Luo ZH, Meng QQ, Zhong PC, Hu YJ, Shen XL (2020) Network pharmacology-based investigation on the mechanisms of action of Morinda officinalis How. in the treatment of osteoporosis. Comput Biol Med 127:104074","journal-title":"Comput Biol Med"},{"issue":"2","key":"1271_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1142\/S2575900018300023","volume":"1","author":"J Lin","year":"2018","unstructured":"Lin J, Lv T, Tian F, Wang Y, Wang M, Tang W et al (2018) Chinese herbal formulas for postmenopausal osteoporosis: a review of preclinical evidence on animal studies and molecular mechanism. Trad Med Mod Med 1(2):75\u201383","journal-title":"Trad Med Mod Med"},{"issue":"2\u20133","key":"1271_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbi.2011.08.013","volume":"194","author":"L Bao","year":"2011","unstructured":"Bao L, Qin L, Liu L, Wu Y, Han T, Xue L et al (2011) Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. Chem Biol Interact 194(2\u20133):97\u2013105","journal-title":"Chem Biol Interact"},{"issue":"7","key":"1271_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/kjm2.12544","volume":"38","author":"PY Wu","year":"2022","unstructured":"Wu PY, Chen W, Huang H, Tang W, Liang J (2022) Morinda officinalis polysaccharide regulates rat bone mesenchymal stem cell osteogenic-adipogenic differentiation in osteoporosis by upregulating miR-21 and activating the PI3K\/AKT pathway. Kaohsiung J Med Sci 38(7):675\u2013685","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1271_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3\u201344","journal-title":"Osteoporos Int"},{"key":"1271_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","volume":"123","author":"V Fischer","year":"2022","unstructured":"Fischer V, Haffner-Luntzer M (2022) Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Semin Cell Dev Biol 123:14\u201321","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"1271_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184904","volume":"12","author":"Y Ozaki","year":"2017","unstructured":"Ozaki Y, Koide M, Furuya Y, Ninomiya T, Yasuda H, Nakamura M et al (2017) Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. PLoS ONE 12(9):e0184904","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"1271_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000495509","volume":"103","author":"Z Ding","year":"2019","unstructured":"Ding Z, Shi H, Yang W (2019) Osteoprotective effect of cimiracemate in glucocorticoid-induced osteoporosis by osteoprotegerin\/receptor activator of nuclear factor kappa B\/receptor activator of nuclear factor kappa-beta ligand signaling. Pharmacology 103(3\u20134):163\u2013172","journal-title":"Pharmacology"},{"issue":"1","key":"1271_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ydbio.2015.12.001","volume":"410","author":"S Wiszniak","year":"2016","unstructured":"Wiszniak S, Harvey N, Schwarz Q (2016) Cell autonomous roles of Nedd4 in craniofacial bone formation. Dev Biol 410(1):98\u2013107","journal-title":"Dev Biol"},{"issue":"17","key":"1271_CR21","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.3390\/ijms23179937","volume":"23","author":"K Xu","year":"2022","unstructured":"Xu K, Chu Y, Liu Q, Fan W, He H, Huang F (2022) NEDD4 E3 ligases: functions and mechanisms in bone and tooth. Int J Mol Sci 23(17):9937","journal-title":"Int J Mol Sci"},{"key":"1271_CR22","doi-asserted-by":"publisher","first-page":"32957","DOI":"10.1038\/srep32957","volume":"6","author":"S Yanpallewar","year":"2016","unstructured":"Yanpallewar S, Wang T, Koh DC, Quarta E, Fulgenzi G, Tessarollo L (2016) Nedd4-2 haploinsufficiency causes hyperactivity and increased sensitivity to inflammatory stimuli. Sci Rep 6:32957","journal-title":"Sci Rep"},{"issue":"19","key":"1271_CR23","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00018-019-03162-w","volume":"76","author":"D Bellavia","year":"2019","unstructured":"Bellavia D, Salamanna F, Raimondi L, De Luca A, Carina V, Costa V et al (2019) Deregulated miRNAs in osteoporosis: effects in bone metastasis. Cell Mol Life Sci 76(19):3723\u20133744","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1271_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan microRNAs. Cell 173(1):20\u201351","journal-title":"Cell"},{"issue":"4","key":"1271_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","volume":"8","author":"JB Lian","year":"2012","unstructured":"Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T et al (2012) MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8(4):212\u2013227","journal-title":"Nat Rev Endocrinol"},{"issue":"17","key":"1271_CR26","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.3390\/ijms21176081","volume":"21","author":"Y Gao","year":"2020","unstructured":"Gao Y, Patil S, Qian A (2020) The role of microRNAs in bone metabolism and disease. Int J Mol Sci 21(17):6081","journal-title":"Int J Mol Sci"},{"key":"1271_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12428","author":"Z Li","year":"2021","unstructured":"Li Z, Xue H, Tan G, Xu Z (2021) Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12428","journal-title":"Mol Med Rep"},{"issue":"9","key":"1271_CR28","doi-asserted-by":"publisher","first-page":"15518","DOI":"10.1002\/jcb.28818","volume":"120","author":"N Mohamad","year":"2019","unstructured":"Mohamad N, Nabih ES, Zakaria ZM, Nagaty MM, Metwaly RG (2019) Insight into the possible role of miR-214 in primary osteoporosis via osterix. J Cell Biochem 120(9):15518\u201315526","journal-title":"J Cell Biochem"},{"issue":"8","key":"1271_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jcyt.2020.04.090","volume":"22","author":"CG Wang","year":"2020","unstructured":"Wang CG, Wang L, Yang T, Su SL, Hu YH, Zhong D (2020) Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis. Cytotherapy 22(8):412\u2013423","journal-title":"Cytotherapy"},{"key":"1271_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.omtn.2019.09.030","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Sun W, Ling S, Wang Y, Wang X, Meng H et al (2019) AAV-Anti-miR-214 prevents collapse of the femoral head in osteonecrosis by regulating osteoblast and osteoclast activities. Mol Ther Nucleic Acids 18:841\u2013850","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"1271_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15476286.2015.1017205","volume":"12","author":"C Zhao","year":"2015","unstructured":"Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D et al (2015) miR-214 promotes osteoclastogenesis by targeting Pten\/PI3k\/Akt pathway. RNA Biol 12(3):343\u2013353","journal-title":"RNA Biol"},{"key":"1271_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112313","volume":"197","author":"S Zhou","year":"2020","unstructured":"Zhou S, Huang G, Chen G (2020) Synthesis and biological activities of drugs for the treatment of osteoporosis. Eur J Med Chem 197:112313","journal-title":"Eur J Med Chem"},{"key":"1271_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/CIA.S164021","volume":"14","author":"M Liu","year":"2019","unstructured":"Liu M, Lu Y, Cheng X, Ma L, Miao X, Li N et al (2019) Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years. Clin Interv Aging 14:445\u2013451","journal-title":"Clin Interv Aging"},{"issue":"22","key":"1271_CR34","first-page":"10860","volume":"27","author":"XB Lin","year":"2023","unstructured":"Lin XB, Ye H, He LJ, Xu ZB (2023) Analysis of changes in serum high t-PINP\/beta-CTX ratio and risk of re-fracture after vertebral osteoporotic fracture surgery. Eur Rev Med Pharmacol Sci 27(22):10860\u201310867","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1271_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.fitote.2016.03.013","volume":"110","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Zhang Q, Yang H, Liu W, Zhang N, Qin L et al (2016) Monotropein isolated from the roots of Morinda officinalis increases osteoblastic bone formation and prevents bone loss in ovariectomized mice. Fitoterapia 110:166\u2013172","journal-title":"Fitoterapia"},{"key":"1271_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154542","volume":"108","author":"C Li","year":"2023","unstructured":"Li C, Tian L, Wang Y, Luo H, Zeng J, Su P et al (2023) M13, an anthraquinone compound isolated from Morinda officinalis promotes the osteogenic differentiation of MSCs by targeting Wnt\/beta-catenin signaling. Phytomedicine 108:154542","journal-title":"Phytomedicine"},{"issue":"1","key":"1271_CR37","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/13880209.2022.2093385","volume":"60","author":"P Wu","year":"2022","unstructured":"Wu P, Jiao F, Huang H, Liu D, Tang W, Liang J et al (2022) Morinda officinalis polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells. Pharm Biol 60(1):1303\u20131316","journal-title":"Pharm Biol"},{"issue":"19","key":"1271_CR38","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.febslet.2012.06.047","volume":"586","author":"J Zhang","year":"2012","unstructured":"Zhang J, Zhao H, Chen J, Xia B, Jin Y, Wei W et al (2012) Interferon-beta-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett 586(19):3255\u20133262","journal-title":"FEBS Lett"},{"issue":"5","key":"1271_CR39","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/jbmr.1845","volume":"28","author":"P Cheng","year":"2013","unstructured":"Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H et al (2013) miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 28(5):1180\u20131190","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1271_CR40","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/ar4282","volume":"15","author":"F Mizoguchi","year":"2013","unstructured":"Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H (2013) miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther 15(5):R102","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1271_CR41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.33549\/physiolres.934917","volume":"71","author":"K Zhang","year":"2022","unstructured":"Zhang K, Liu X, Tang Y, Liu Z, Yi Q, Wang L et al (2022) Fluid shear stress promotes osteoblast proliferation and suppresses mitochondrial-mediated osteoblast apoptosis through the miR-214-3p-ATF4 signaling axis. Physiol Res 71(4):527\u2013538","journal-title":"Physiol Res"},{"key":"1271_CR42","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1038\/ncomms10872","volume":"7","author":"D Li","year":"2016","unstructured":"Li D, Liu J, Guo B, Liang C, Dang L, Lu C et al (2016) Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun 7:10872","journal-title":"Nat Commun"},{"issue":"2","key":"1271_CR43","first-page":"2620","volume":"16","author":"H Cai","year":"2018","unstructured":"Cai H, Miao M, Wang Z (2018) miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1. Oncol Lett 16(2):2620\u20132628","journal-title":"Oncol Lett"},{"issue":"10","key":"1271_CR44","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.7150\/ijbs.51638","volume":"17","author":"S Hu","year":"2021","unstructured":"Hu S, Chang J, Ruan H, Zhi W, Wang X, Zhao F et al (2021) Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p\/DKK3 axis to inactivate beta-catenin nuclear translocation and LEF1 translation. Int J Biol Sci 17(10):2504\u20132522","journal-title":"Int J Biol Sci"},{"issue":"2","key":"1271_CR45","first-page":"92","volume":"35","author":"G Cheng","year":"2020","unstructured":"Cheng G, Xu D, Chu K, Cao Z, Sun X, Yang Y (2020) The effects of MiR-214-3p and Irisin\/FNDC5 on the biological behavior of osteosarcoma cells. Cancer Biother Radiopharm 35(2):92\u2013100","journal-title":"Cancer Biother Radiopharm"},{"key":"1271_CR46","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.2147\/CMAR.S232757","volume":"12","author":"X Yao","year":"2020","unstructured":"Yao X, Wu L, Gu Z, Li J (2020) LINC01535 promotes the development of osteosarcoma through modulating miR-214-3p\/KCNC4 axis. Cancer Manag Res 12:5575\u20135585","journal-title":"Cancer Manag Res"},{"issue":"7","key":"1271_CR47","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1007\/s11033-022-07136-3","volume":"49","author":"J Li","year":"2022","unstructured":"Li J, Zhuang H, Wang Z, Cai J, Ma X, Chen W et al (2022) lncRNAs MALAT1 and LINC00657 upstream to miR-214-3p\/BMP2 regulate osteogenic differentiation of human mesenchymal stem cells. Mol Biol Rep 49(7):6847\u20136857","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1271_CR48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001080RR","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Li X, Li J, Zhai L, Liu D, Abdurahman A et al (2021) Mechanical loading stimulates bone angiogenesis through enhancing type H vessel formation and downregulating exosomal miR-214-3p from bone marrow-derived mesenchymal stem cells. FASEB J 35(1):e21150","journal-title":"FASEB J"},{"issue":"1","key":"1271_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/cdd.2009.84","volume":"17","author":"B Yang","year":"2010","unstructured":"Yang B, Kumar S (2010) Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions. Cell Death Differ 17(1):68\u201377","journal-title":"Cell Death Differ"},{"issue":"6","key":"1271_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1083\/jcb.201611177","volume":"215","author":"YG Zhao","year":"2016","unstructured":"Zhao YG, Zhang H (2016) ULK1 cycling: the ups and downs of the autophagy response. J Cell Biol 215(6):757\u2013759","journal-title":"J Cell Biol"},{"issue":"6","key":"1271_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrm2690","volume":"10","author":"D Rotin","year":"2009","unstructured":"Rotin D, Kumar S (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 10(6):398\u2013409","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"1271_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081514","volume":"8","author":"JP Tanksley","year":"2013","unstructured":"Tanksley JP, Chen X, Coffey RJ (2013) NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling. PLoS ONE 8(11):e81514","journal-title":"PLoS ONE"},{"issue":"6","key":"1271_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2174\/1568009614666140725092430","volume":"14","author":"X Ye","year":"2014","unstructured":"Ye X, Wang L, Shang B, Wang Z, Wei W (2014) NEDD4: a promising target for cancer therapy. Curr Cancer Drug Targets 14(6):549\u2013556","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01271-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T18:04:34Z","timestamp":1730570674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01271-8","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors Hui Huang, Jian Chen, Xiaomei Lin, and Zhengkun Lin have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Shanghai Experimental Animal Center (Certificate No.: 20180006024876; License No.: SCXK (Shanghai) 2018\u2013006). All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed, and the authors complied with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}